Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 17 studies | 54% ± 20% | |
epithelial cell | 8 studies | 30% ± 16% | |
erythroblast | 5 studies | 34% ± 11% | |
fibroblast | 5 studies | 23% ± 7% | |
natural killer cell | 5 studies | 20% ± 4% | |
endothelial cell | 5 studies | 23% ± 7% | |
hematopoietic precursor cell | 4 studies | 30% ± 9% | |
deuterosomal cell | 4 studies | 49% ± 12% | |
smooth muscle cell | 4 studies | 21% ± 3% | |
basal cell | 4 studies | 25% ± 10% | |
CD4-positive, alpha-beta T cell | 4 studies | 29% ± 7% | |
CD8-positive, alpha-beta T cell | 4 studies | 24% ± 7% | |
plasmablast | 3 studies | 48% ± 7% | |
common myeloid progenitor | 3 studies | 29% ± 12% | |
myofibroblast cell | 3 studies | 18% ± 1% | |
pericyte | 3 studies | 22% ± 2% | |
precursor B cell | 3 studies | 19% ± 1% | |
abnormal cell | 3 studies | 24% ± 6% | |
dendritic cell | 3 studies | 26% ± 8% | |
intestinal crypt stem cell | 3 studies | 19% ± 2% | |
erythrocyte | 3 studies | 41% ± 15% | |
effector CD8-positive, alpha-beta T cell | 3 studies | 20% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3140.73 | 1445 / 1445 | 100% | 89.33 | 183 / 183 |
liver | 100% | 2035.48 | 226 / 226 | 100% | 65.20 | 406 / 406 |
ovary | 100% | 2600.29 | 180 / 180 | 100% | 95.67 | 430 / 430 |
skin | 100% | 3961.60 | 1809 / 1809 | 100% | 125.78 | 472 / 472 |
uterus | 100% | 2945.14 | 170 / 170 | 100% | 127.85 | 459 / 459 |
thymus | 100% | 2908.29 | 653 / 653 | 100% | 90.54 | 604 / 605 |
brain | 100% | 2658.75 | 2637 / 2642 | 100% | 86.85 | 705 / 705 |
intestine | 100% | 2679.67 | 966 / 966 | 100% | 125.05 | 525 / 527 |
stomach | 100% | 2259.89 | 359 / 359 | 99% | 106.66 | 284 / 286 |
breast | 100% | 2707.69 | 459 / 459 | 99% | 95.96 | 1110 / 1118 |
prostate | 100% | 2784.62 | 245 / 245 | 99% | 86.38 | 498 / 502 |
adrenal gland | 100% | 2832.84 | 258 / 258 | 99% | 66.05 | 228 / 230 |
kidney | 100% | 2639.74 | 89 / 89 | 99% | 68.00 | 893 / 901 |
bladder | 100% | 2704.67 | 21 / 21 | 99% | 116.38 | 499 / 504 |
lung | 100% | 2657.10 | 576 / 578 | 99% | 86.18 | 1143 / 1155 |
pancreas | 100% | 1679.24 | 327 / 328 | 98% | 73.34 | 175 / 178 |
adipose | 100% | 2373.28 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 145.62 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 140.55 | 29 / 29 |
muscle | 100% | 3730.29 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2431.41 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 116.83 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 87.74 | 1 / 1 |
blood vessel | 100% | 2480.94 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 2317.17 | 848 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 2208.14 | 862 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032508 | Biological process | DNA duplex unwinding |
GO_0006281 | Biological process | DNA repair |
GO_0045995 | Biological process | regulation of embryonic development |
GO_2000779 | Biological process | regulation of double-strand break repair |
GO_0034644 | Biological process | cellular response to UV |
GO_0071169 | Biological process | establishment of protein localization to chromatin |
GO_0045739 | Biological process | positive regulation of DNA repair |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0006282 | Biological process | regulation of DNA repair |
GO_1904874 | Biological process | positive regulation of telomerase RNA localization to Cajal body |
GO_0071392 | Biological process | cellular response to estradiol stimulus |
GO_0060382 | Biological process | regulation of DNA strand elongation |
GO_1904507 | Biological process | positive regulation of telomere maintenance in response to DNA damage |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0006338 | Biological process | chromatin remodeling |
GO_0006457 | Biological process | protein folding |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0000492 | Biological process | box C/D snoRNP assembly |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0050821 | Biological process | protein stabilization |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0000723 | Biological process | telomere maintenance |
GO_0033044 | Biological process | regulation of chromosome organization |
GO_1905168 | Biological process | positive regulation of double-strand break repair via homologous recombination |
GO_0006310 | Biological process | DNA recombination |
GO_0006275 | Biological process | regulation of DNA replication |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000812 | Cellular component | Swr1 complex |
GO_0071339 | Cellular component | MLL1 complex |
GO_0000786 | Cellular component | nucleosome |
GO_1990062 | Cellular component | RPAP3/R2TP/prefoldin-like complex |
GO_0016020 | Cellular component | membrane |
GO_0005813 | Cellular component | centrosome |
GO_0000791 | Cellular component | euchromatin |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0035267 | Cellular component | NuA4 histone acetyltransferase complex |
GO_0016363 | Cellular component | nuclear matrix |
GO_0120293 | Cellular component | dynein axonemal particle |
GO_0101031 | Cellular component | protein folding chaperone complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0097255 | Cellular component | R2TP complex |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0031011 | Cellular component | Ino80 complex |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0017025 | Molecular function | TBP-class protein binding |
GO_0043531 | Molecular function | ADP binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140585 | Molecular function | promoter-enhancer loop anchoring activity |
GO_0001094 | Molecular function | TFIID-class transcription factor complex binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0008013 | Molecular function | beta-catenin binding |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0003678 | Molecular function | DNA helicase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0051117 | Molecular function | ATPase binding |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0000979 | Molecular function | RNA polymerase II core promoter sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | RUVBL2 |
Protein name | RuvB-like helicase (EC 3.6.4.12) RuvB like AAA ATPase 2 (RuvB-like 2 (E. coli), isoform CRA_c) RuvB like AAA ATPase 2 (RuvB-like 2 (E. coli), isoform CRA_b) RuvB like AAA ATPase 2 RuvB-like 2 (EC 3.6.4.12) (48 kDa TATA box-binding protein-interacting protein) (48 kDa TBP-interacting protein) (51 kDa erythrocyte cytosolic protein) (ECP-51) (INO80 complex subunit J) (Repressing pontin 52) (Reptin 52) (TIP49b) (TIP60-associated protein 54-beta) (TAP54-beta) |
Synonyms | TIP49B hCG_16214 INO80J CGI-46 TIP48 |
Description | FUNCTION: Possesses single-stranded DNA-stimulated ATPase and ATP-dependent DNA helicase (5' to 3') activity; hexamerization is thought to be critical for ATP hydrolysis and adjacent subunits in the ring-like structure contribute to the ATPase activity . Component of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A . This modification may both alter nucleosome -DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription . This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair . The NuA4 complex ATPase and helicase activities seem to be, at least in part, contributed by the association of RUVBL1 and RUVBL2 with EP400 . NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage . Component of a SWR1-like complex that specifically mediates the removal of histone H2A.Z/H2AZ1 from the nucleosome . Proposed core component of the chromatin remodeling INO80 complex which exhibits DNA- and nucleosome-activated ATPase activity and catalyzes ATP-dependent nucleosome sliding . Plays an essential role in oncogenic transformation by MYC and also modulates transcriptional activation by the LEF1/TCF1-CTNNB1 complex . May also inhibit the transcriptional activity of ATF2 . Involved in the endoplasmic reticulum (ER)-associated degradation (ERAD) pathway where it negatively regulates expression of ER stress response genes . May play a role in regulating the composition of the U5 snRNP complex . . FUNCTION: Proposed core component of the chromatin remodeling Ino80 complex which exhibits DNA- and nucleosome-activated ATPase activity and catalyzes ATP-dependent nucleosome sliding. . FUNCTION: Proposed core component of the chromatin remodeling Ino80 complex which exhibits DNA- and nucleosome-activated ATPase activity and catalyzes ATP-dependent nucleosome sliding. . FUNCTION: Proposed core component of the chromatin remodeling Ino80 complex which exhibits DNA- and nucleosome-activated ATPase activity and catalyzes ATP-dependent nucleosome sliding. . FUNCTION: Proposed core component of the chromatin remodeling Ino80 complex which exhibits DNA- and nucleosome-activated ATPase activity and catalyzes ATP-dependent nucleosome sliding. . |
Accessions | Q9Y230 ENST00000595090.6 [Q9Y230-1] ENST00000593570.5 ENST00000596247.5 B3KNL2 X6R2L4 M0R0Z0 ENST00000596837.5 M0QXI6 M0QYD8 ENST00000595811.5 ENST00000601968.5 ENST00000627972.1 ENST00000221413.10 M0QXZ7 M0R0Y3 |